Skip to main content

Dr. Soni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Soni's full profile

Already have an account?

  • Office

    455 S Main St
    PSF Hematology
    Orange, CA 92868
    Phone+1 714-532-8459
    Fax+1 714-532-8771

Education & Training

  • University of California (Irvine)/Children's Hospital of Orange County
    University of California (Irvine)/Children's Hospital of Orange CountyFellowship, Pediatric Hematology/Oncology, 2004 - 2007
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolResidency, Pediatrics, 2001 - 2004
  • St. George's University School of Medicine
    St. George's University School of MedicineClass of 2000

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - 2025
  • NJ State Medical License
    NJ State Medical License 2002 - 2006
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Training Program DirectorsÍ Workshop 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Training Program DirectorsÍ Workshop 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Praxis Media Announces Winners of Its National Healthcare Excellence Awards, 2016 in New Delhi
    Praxis Media Announces Winners of Its National Healthcare Excellence Awards, 2016 in New DelhiSeptember 28th, 2016
  • Center for Inherited Blood Disorders Administers Country's First Gene Therapy Infusion to Treat Hemophilia A
    Center for Inherited Blood Disorders Administers Country's First Gene Therapy Infusion to Treat Hemophilia AJanuary 13th, 2024
  • Approved Roctavian ‘Liberating’ for 1st US Patient Treated Outside Trials
    Approved Roctavian ‘Liberating’ for 1st US Patient Treated Outside TrialsJanuary 14th, 2024